Literature DB >> 18680390

In vitro differentiation of adult bone marrow progenitors into antigen-specific CD4 helper T cells using engineered stromal cells expressing a notch ligand and a major histocompatibility complex class II protein.

Bingbing Dai1, Pin Wang.   

Abstract

A murine stromal cell line (OP9-DL1) expressing a notch ligand, Delta-like-1, has been shown to be able to drive the differentiation of both murine and human hematopoietic progenitors into T cells in vitro. Further studies showed that hematopoietic progenitors transduced by a retroviral vector to express a human CD8 T-cell receptor (TCR) followed by an OP9-DL1 monolayer coculture could generate antigen-specific cytotoxic T lymphocytes in vitro. It remains unknown if a similar method could be applied to produce CD4 helper T cells. In this report, we show that murine adult bone marrow (BM) cells transduced with an OT2 CD4 TCR and cocultured with OP9 stromal cells expressing Delta-like-1 can differentiate into antigen-specific CD4 T cells in vitro. These cells are capable of inducing the expression of T-cell activation markers and producing cytokines upon stimulation. We have also constructed a new stromal cell line (OP9-DL1-IA(b)) ectopically expressing a murine major histocompatibility complex class II protein, I-A(b), in OP9-DL1 cells. This new line could accelerate the development of TCR-transduced BM cells into CD4 T cells, resulting in cells with an improved capacity to respond to T-cell stimulation to secrete cytokines. Taken together, we demonstrate a general and potentially useful method to generate autologous antigen-specific CD4 helper T cells in vitro from easily accessible BM cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18680390      PMCID: PMC2656584          DOI: 10.1089/scd.2008.0021

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  50 in total

1.  Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity.

Authors:  A L Marzo; B F Kinnear; R A Lake; J J Frelinger; E J Collins; B W Robinson; B Scott
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

2.  Generation of functional antigen-specific T cells in defined genetic backgrounds by retrovirus-mediated expression of TCR cDNAs in hematopoietic precursor cells.

Authors:  Lili Yang; Xiao-Feng Qin; David Baltimore; Luk Van Parijs
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

3.  CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes.

Authors:  Edith M Janssen; Edward E Lemmens; Tom Wolfe; Urs Christen; Matthias G von Herrath; Stephen P Schoenberger
Journal:  Nature       Date:  2003-02-09       Impact factor: 49.962

Review 4.  Lymphocyte commitment during embryonic development, in the mouse.

Authors:  Iyadh Douagi; Paulo Vieira; Ana Cumano
Journal:  Semin Immunol       Date:  2002-12       Impact factor: 11.130

5.  Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro.

Authors:  Thomas M Schmitt; Juan Carlos Zúñiga-Pflücker
Journal:  Immunity       Date:  2002-12       Impact factor: 31.745

Review 6.  A positive look at double-negative thymocytes.

Authors:  Rod Ceredig; Ton Rolink
Journal:  Nat Rev Immunol       Date:  2002-11       Impact factor: 53.106

Review 7.  Commitment and developmental potential of extrathymic and intrathymic T cell precursors: plenty to choose from.

Authors:  Avinash Bhandoola; Harald von Boehmer; Howard T Petrie; Juan Carlos Zúñiga-Pflücker
Journal:  Immunity       Date:  2007-06       Impact factor: 31.745

8.  Functional human antigen-specific T cells produced in vitro using retroviral T cell receptor transfer into hematopoietic progenitors.

Authors:  Anja U van Lent; Maho Nagasawa; Marleen M van Loenen; Remko Schotte; Ton N M Schumacher; Mirjam H M Heemskerk; Hergen Spits; Nicolas Legrand
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

9.  Immunotherapy through TCR gene transfer.

Authors:  H W Kessels; M C Wolkers; M D van den Boom; M A van der Valk; T N Schumacher
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

10.  Arrested B lymphopoiesis and persistence of activated B cells in adult interleukin 7(-/)- mice.

Authors:  T L Carvalho; T Mota-Santos; A Cumano; J Demengeot; P Vieira
Journal:  J Exp Med       Date:  2001-10-15       Impact factor: 14.307

View more
  6 in total

1.  Pre-T Cell Receptors (Pre-TCRs) Leverage Vβ Complementarity Determining Regions (CDRs) and Hydrophobic Patch in Mechanosensing Thymic Self-ligands.

Authors:  Dibyendu Kumar Das; Robert J Mallis; Jonathan S Duke-Cohan; Rebecca E Hussey; Paul W Tetteh; Mark Hilton; Gerhard Wagner; Matthew J Lang; Ellis L Reinherz
Journal:  J Biol Chem       Date:  2016-10-05       Impact factor: 5.157

2.  Programming of regulatory T cells from pluripotent stem cells and prevention of autoimmunity.

Authors:  Rizwanul Haque; Fengyang Lei; Xiaofang Xiong; Yanqing Bian; Baohua Zhao; Yuzhang Wu; Jianxun Song
Journal:  J Immunol       Date:  2012-06-25       Impact factor: 5.422

Review 3.  Targeting Stem Cell-Derived Tissue-Associated Regulatory T Cells for Type 1 Diabetes Immunotherapy.

Authors:  Mohammad Haque; Jugal Kishore Das; Xiaofang Xiong; Jianxun Song
Journal:  Curr Diab Rep       Date:  2019-08-30       Impact factor: 4.810

4.  Modulation of autoimmune diseases by iPS cells.

Authors:  Fengyang Lei; Rizwanul Haque; Xiaofang Xiong; Jianxun Song
Journal:  Methods Mol Biol       Date:  2014

5.  Osteogenic differentiation of mesenchymal stem cells on pregenerated extracellular matrix scaffolds in the absence of osteogenic cell culture supplements.

Authors:  Richard A Thibault; L Scott Baggett; Antonios G Mikos; F Kurtis Kasper
Journal:  Tissue Eng Part A       Date:  2010-02       Impact factor: 3.845

Review 6.  Isolation, Maintenance and Expansion of Adult Hematopoietic Stem/Progenitor Cells and Leukemic Stem Cells.

Authors:  Isabella Maria Mayer; Andrea Hoelbl-Kovacic; Veronika Sexl; Eszter Doma
Journal:  Cancers (Basel)       Date:  2022-03-28       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.